Pershing Square Files 13D on Valeant Pharma (VRX); May Conduct Talks with Management
Tweet Send to a Friend
In a 13D filing on Valeant Pharma (NYSE: VRX), hedge fund Pershing Square Capital disclosed a 5.7%, or 19,473,933 share ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
